dimyristoylphosphatidylcholine has been researched along with Lymphoma, Primary Effusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komizu, Y; Matsumoto, Y; Okada, S; Suzu, S; Towata, T; Ueoka, R | 1 |
| Komizu, Y; Okada, S; Suzu, S; Towata, T; Ueoka, R | 1 |
2 other study(ies) available for dimyristoylphosphatidylcholine and Lymphoma, Primary Effusion
| Article | Year |
|---|---|
Hybrid liposomes inhibit the growth of primary effusion lymphoma in vitro and in vivo.
Topics: Animals; Apoptosis; Ascites; Cell Division; Dimyristoylphosphatidylcholine; Humans; Janus Kinase 3; Liposomes; Lymphoma, Primary Effusion; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Polyethylene Glycols; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
Highly selective fusion and accumulation of hybrid liposomes into primary effusion lymphoma cells along with induction of apoptosis.
Topics: Apoptosis; Cell Line, Tumor; Cell Membrane; Dimyristoylphosphatidylcholine; Humans; Liposomes; Lymphoma, Primary Effusion; Membrane Fluidity; Membrane Fusion; Polidocanol; Polyethylene Glycols | 2010 |